Recent News

• Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System October 8, 2024
• CSA Medical Announces New Scientific Data Utilizing Metered Cryospray with the RejuvenAir® System for the Treatment of Chronic Bronchitis September 16, 2024
• CSA Medical Raises $53 Million in Series D Financing to Support PMA of the RejuvenAir System September 9, 2024
• CSA Medical Announces 500th Metered CryoSpray Procedure for the Treatment of Chronic Bronchitis February 7, 2024
• First Randomized Controlled Study with RejuvenAir for Chronic Bronchitis shows Clinically Significant Results September 6, 2022
• CSA Medical Announces Completion of Enrollment in Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis May 13, 2021
• CSA Medical, Inc. Announces Cooper University Health Care is the 20th Clinical Site to Join the SPRAY-CB Pivotal Study for the treatment of Chronic Bronchitis April 19, 2021
• CSA Medical Announces Metered Cryospray with the RejuvenAir® System for the treatment of Chronic Bronchitis Featured at the 21st World Congress of Bronchology and Interventional Pulmonology November 23, 2020
• CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis November 11, 2020
• CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis October 22, 2020